Delivery Order SPE2DB20D1109-SPE2DB22FN60M
Award Date 2/11/22
Potential Completion Date 2/14/22
Potential Value $3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,251.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Orilissa 150 mg tablets, a specialty medication. The order has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Orilissa 150 mg tablets. The contract, valued at $8,753.96, is a firm fixed-price delivery order with an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,402.40 firm fixed price contract is for the supply of the prescription medication Orilissa 150 mg tablets, with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
- This is a delivery order (SPE2DB22D2007|SPE2DB24FJ0FZ) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,361.44, is for the delivery of the drug Orilissa 150 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. The IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,651.12 firm fixed-price delivery order is for the drug Orilissa 150 mg tablet, with a completion date of May 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the pharmaceutical product Orilissa 150 mg Tablet 7s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,642.34 and an ultimate completion date of August 2, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, will provide the Orilissa medication to support various...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Orilissa 150 mg tablet product. The contract has a ceiling value of $3,714.97 and an ultimate completion date of April 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, will deliver the prescription medication to DLA facilities supporting the Department of Defense worldwide. This contract is part...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets, a medication used to treat endometriosis. The award has a ceiling value of $3,100.78 and a completion date of June 26, 2025. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,406.31 firm fixed-price delivery order is for the supply of the prescription medication Orilissa 200 mg tablets. The contract has an ultimate completion date of August 13, 2024. While no set-aside designation is mentioned, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $2,894.95 contract is for the delivery of the pharmaceutical product Orilissa 150 mg tablets. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...